World Health Organization : Press Release, Year 2006 : Press Release Statement, Issue 24: Countries Provide Successful Model for Massive Tuberculosis Treatment Scale-Up Target to Treat 800,000 Patients and Prevent Emergence of Incurable TB Strains

By World Health Organization

Book Id: WPLBN0000110971
Format Type: PDF eBook:
File Size: 0.2 MB
Reproduction Date: 2005

Title:	World Health Organization : Press Release, Year 2006 : Press Release Statement, Issue 24: Countries Provide Successful Model for Massive Tuberculosis Treatment Scale-Up Target to Treat 800,000 Patients and Prevent Emergence of Incurable TB Strains
Author:	World Health Organization
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Health Organization, B. W. (n.d.). World Health Organization : Press Release, Year 2006 : Press Release Statement, Issue 24. Retrieved from https://self.gutenberg.org/

Description
Medical Reference Publication

Excerpt
Atlanta, USA - Findings from a series of projects have clearly demonstrated that multidrug-resistant tuberculosis (MDR-TB) can be effectively treated in low-income countries and also provide a solid foundation for rapidly expanding TB control programmes. The conclusions present a major rethink on the feasibility of addressing the threat of drug resistant TB in poor countries. The new World Health Organization (WHO) guidelines, encompassing the lessons learnt from 46 projects, and implemented in 29 countries* since 2000, were released at a gathering of TB experts in Atlanta. The successful strategies that form the 'Guidelines for Programmatic Management of Drug-Resistant TB' will underpin actions outlined in the Global Plan to Stop TB 2006-201 5. The goal is to rapidly increase the number of MDR-TB patients treated during the next decade - from currently 16,000 patients - to a cumulative total of 800,000 treated patients. The guidelines give practical advice on how to provide treatment to patients with drug resistant TB, based on the best evidence available and with the best drugs. MDR-TB was once considered a death sentence for most patients in poor countries, said WHO Director-General, Dr LEE Jong-wook. These evidence-based guidelines and their conclusions show that it is possible to develop effective and affordable ways to treat MDRTB patients in poor countries.

Table of Contents
NA